Disposition of 3786 shares by Rajeev Singh of Accolade subject to Rule 16b-3
ACCD Stock | USD 3.80 0.10 2.70% |
About 57% of all Accolade's shareholders are looking to take a long position. The analysis of the overall investor sentiment regarding Accolade suggests that some traders are interested. The current market sentiment, together with Accolade's historical and current headlines, can help investors time the market. In addition, many technical investors use Accolade stock news signals to limit their universe of possible portfolio assets.
Accolade |
Filed transaction by Accolade Director, Officer: Chief Executive Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Cash Flow Correlation
Accolade's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Accolade's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Accolade Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Accolade can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Accolade Fundamental Analysis
We analyze Accolade's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Accolade using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Accolade based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Accolade is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Accolade Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Accolade stock to make a market-neutral strategy. Peer analysis of Accolade could also be used in its relative valuation, which is a method of valuing Accolade by comparing valuation metrics with similar companies.
Peers
Accolade Related Equities
EVH | Evolent Health | 8.53 | ||||
CERT | Certara | 6.66 | ||||
HCAT | Health Catalyst | 4.80 | ||||
PRVA | Privia Health | 4.13 | ||||
NRC | National Research | 2.72 | ||||
PHR | Phreesia | 2.47 | ||||
DH | Definitive Healthcare | 1.83 | ||||
PINC | Premier | 1.40 | ||||
HSTM | HealthStream | 1.06 | ||||
RCM | R1 RCM | 0.07 | ||||
CMAX | CareMax | 4.17 |
Complementary Tools for Accolade Stock analysis
When running Accolade's price analysis, check to measure Accolade's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accolade is operating at the current time. Most of Accolade's value examination focuses on studying past and present price action to predict the probability of Accolade's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accolade's price. Additionally, you may evaluate how the addition of Accolade to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |